Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

INTRODUCTION: Patients with multiple sclerosis may have a distinct gut microbiota profile. Delayed-release dimethyl fumarate is an orally administered drug for relapsing–remitting multiple sclerosis, which has been associated with gastrointestinal side-effects in some patients. OBJECTIVES: The purpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Storm-Larsen, C, Myhr, K-M, Farbu, E, Midgard, R, Nyquist, K, Broch, L, Berg-Hansen, P, Buness, A, Holm, K, Ueland, T, Fallang, L-E, Burum-Auensen, E, Hov, JR, Holmøy, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859687/
https://www.ncbi.nlm.nih.gov/pubmed/31798939
http://dx.doi.org/10.1177/2055217319888767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859687/
https://www.ncbi.nlm.nih.gov/pubmed/31798939
http://dx.doi.org/10.1177/2055217319888767

Ejemplares similares